Completed OBSERVATIONAL NCT02585635

Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia (MOrPH)

Sponsor: Neuroscience Research Australia

Updated 7 times since 2017 Last updated: Mar 27, 2018 Started: Mar 31, 2016 Primary completion: Feb 1, 2018 Completion: Feb 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hemophilia, this trial is completed. The trial is conducted by Neuroscience Research Australia and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Status: Enrolling By Invitation → Completed · Phase: NA → None

▶ Show 2 earlier versions

Oct 2017 — Apr 2018 [monthly]

Enrolling By Invitation NA
Jan 2017 — Oct 2017 [monthly]

Enrolling By Invitation NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuroscience Research Australia
Royal Children's Hospital
Sydney Children's Hospitals Network
The George Institute

Data source: Neuroscience Research Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.